CA3023867A1 - Selection of bacterial strains useful in allergy treatment - Google Patents

Selection of bacterial strains useful in allergy treatment Download PDF

Info

Publication number
CA3023867A1
CA3023867A1 CA3023867A CA3023867A CA3023867A1 CA 3023867 A1 CA3023867 A1 CA 3023867A1 CA 3023867 A CA3023867 A CA 3023867A CA 3023867 A CA3023867 A CA 3023867A CA 3023867 A1 CA3023867 A1 CA 3023867A1
Authority
CA
Canada
Prior art keywords
dagk
strain
allergy
bacterial strain
bacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3023867A
Other languages
English (en)
French (fr)
Inventor
James Versalovic
Bo Mollstam
Bhanu Priya GANESH
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogaia AB
Original Assignee
Biogaia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia AB filed Critical Biogaia AB
Publication of CA3023867A1 publication Critical patent/CA3023867A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CA3023867A 2016-05-09 2017-05-08 Selection of bacterial strains useful in allergy treatment Pending CA3023867A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1650620 2016-05-09
SE1650620-6 2016-05-09
PCT/SE2017/050455 WO2017196235A1 (en) 2016-05-09 2017-05-08 Selection of bacterial strains useful in allergy treatment

Publications (1)

Publication Number Publication Date
CA3023867A1 true CA3023867A1 (en) 2017-11-16

Family

ID=58873850

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3023867A Pending CA3023867A1 (en) 2016-05-09 2017-05-08 Selection of bacterial strains useful in allergy treatment

Country Status (11)

Country Link
US (2) US11135255B2 (https=)
EP (1) EP3454874A1 (https=)
JP (1) JP7030716B2 (https=)
CN (1) CN109195612A (https=)
AU (1) AU2017262408A1 (https=)
BR (1) BR112018072511A2 (https=)
CA (1) CA3023867A1 (https=)
CL (1) CL2018003167A1 (https=)
MX (1) MX392754B (https=)
SG (1) SG11201809551TA (https=)
WO (1) WO2017196235A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4081229B1 (en) * 2019-12-24 2026-02-25 Iowa State University Research Foundation, Inc. Control of histamine to increase feeding efficiency and treat or prevent preventing and/or treating clostridial dermatitis and/or clostridial enteric disease using brevibacterium aureum, brevibacterium sediminis, and/or brevibacterium epidermidis
JP7515153B2 (ja) * 2020-03-06 2024-07-12 学校法人麻布獣医学園 乳酸菌含有組成物
CN113073066B (zh) * 2021-04-16 2022-01-04 段云峰 罗伊氏乳杆菌及其应用、组合物、药物和食品
CN114317326B (zh) * 2021-12-06 2023-09-12 浙江工商大学 一种用于缓解过敏反应的清酒乳杆菌及制备方法
CN115025130A (zh) * 2022-06-02 2022-09-09 广东南芯医疗科技有限公司 罗伊氏乳杆菌e9在制备治疗或预防过敏性疾病药物中的应用
CN116376758B (zh) * 2023-03-15 2024-07-02 广东南芯医疗科技有限公司 詹氏乳杆菌ls06及其在制备治疗或预防过敏性疾病药物中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154078C (da) * 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
JP4212838B2 (ja) * 2002-06-26 2009-01-21 カルピス株式会社 抗アレルギー剤
AU2002951270A0 (en) * 2002-09-06 2002-09-19 Vri Biomedical Ltd Probiotic Bacterium and Methods of Use
KR100507417B1 (ko) 2003-01-27 2005-08-10 (주) 피엘바이오 알레르기 질환 예방 및 치료 기능을 가진 유산균과 이를 함유한 항알레르기 제품
AU2005303893A1 (en) 2004-11-11 2006-05-18 Argenta Discovery Ltd Pyrimidine compounds as histamine modulators
US8017592B2 (en) * 2006-04-13 2011-09-13 Alcon Research, Ltd. RNAi-mediated inhibition of histamine receptor H1-related conditions
JP2008127365A (ja) 2006-11-24 2008-06-05 Kowa Co アレルギー性疾患の予防及び／又は治療剤
US20110217290A1 (en) * 2008-08-18 2011-09-08 Manel Jordana Treatment and/or prevention of peanut induced anaphylaxis
JP2011254773A (ja) 2010-06-11 2011-12-22 Bio Plan:Kk 乳酸菌の菌株及びこれを利用したアレルギー抑制剤
WO2012012390A1 (en) * 2010-07-19 2012-01-26 Marvphyt Development Llc Botanical composition and methods of manufacture and use
US20130022586A1 (en) * 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
WO2014130759A1 (en) * 2013-02-21 2014-08-28 University Of Rochester Methods of using histamine receptor agonists and antagonists
JP6195268B2 (ja) 2013-07-18 2017-09-13 国立大学法人徳島大学 鼻炎の予防治療装置
MX2017012359A (es) * 2015-03-26 2018-07-06 Biogaia Ab Cepas bacterianas productoras de histamina y su uso en cancer.

Also Published As

Publication number Publication date
US20220008491A1 (en) 2022-01-13
BR112018072511A2 (pt) 2019-03-12
JP2019520801A (ja) 2019-07-25
US11135255B2 (en) 2021-10-05
WO2017196235A1 (en) 2017-11-16
US12201656B2 (en) 2025-01-21
MX2018013660A (es) 2019-02-28
SG11201809551TA (en) 2018-11-29
US20190142877A1 (en) 2019-05-16
EP3454874A1 (en) 2019-03-20
CN109195612A (zh) 2019-01-11
CL2018003167A1 (es) 2018-12-21
AU2017262408A1 (en) 2018-11-15
MX392754B (es) 2025-03-24
JP7030716B2 (ja) 2022-03-07

Similar Documents

Publication Publication Date Title
US12201656B2 (en) Selection of bacterial strains useful in allergy treatment
JP7292877B2 (ja) １型糖尿病を処置するための組成物および方法
CN101688171B (zh) 益生双歧杆菌菌株
CN101679938B (zh) 益生双歧杆菌菌株
ES2600963T3 (es) Células/Cepas Lactobacillus secadas por pulverización y su uso contra Helicobacter pylori
US12359210B2 (en) Genetically modified bacteria stably expressing IL-10 and insulin
KR20190056387A (ko) 점막부착성 미생물
US20240082321A1 (en) Stimulation of the growth of gut bifidobacteria
Todorov et al. Bacteriocin production and resistance to drugs are advantageous features for Lactobacillus acidophilus La-14, a potential probiotic strain
JPWO2018181071A1 (ja) 非コラーゲン性糖タンパク質分解用組成物
CN110267676A (zh) 用于治疗肠易激综合征或炎性肠病的微生物溶菌酶
CN1760360A (zh) 发酵乳酸杆菌GM－090及其在刺激INF－γ分泌及/或治疗过敏的用途
HK40001496A (en) Selection of bacterial strains useful in allergy treatment
LeBlanc et al. Mechanisms involved in the anti-inflammatory properties of native and genetically engineered lactic acid bacteria
KR102698962B1 (ko) 수퍼옥시드 디스뮤타제를 발현하는 바실러스 종 균주, 바실러스 종 균주 포자 및/또는 수퍼옥시드 디스뮤타제 및 이의 섬유화 질환 예방 또는 치료용 용도
EP4355343A1 (en) Compositions for increasing resilience towards bacterial infections
Zhang Intestinal delivery of heterologous peptides with lactobacilli
HK1141554B (en) Probiotic bifidobacterium strains
IE20080245A1 (en) Probiotic Bifidobacteria strains
IE20080244A1 (en) Probiotic Bifidobacteria strains

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220509

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20241004

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250115

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 8TH ANNIV.) - STANDARD

Year of fee payment: 8

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250507

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250507

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20250518

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20250518

D22 Grant of ip right intended

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D22-D128 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALLOWANCE REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20251210

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251216